Thomas Grader‐Beck

867 total citations
30 papers, 537 citations indexed

About

Thomas Grader‐Beck is a scholar working on Physiology, Rheumatology and Immunology. According to data from OpenAlex, Thomas Grader‐Beck has authored 30 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 13 papers in Rheumatology and 9 papers in Immunology. Recurrent topics in Thomas Grader‐Beck's work include Salivary Gland Disorders and Functions (14 papers), Systemic Lupus Erythematosus Research (9 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Thomas Grader‐Beck is often cited by papers focused on Salivary Gland Disorders and Functions (14 papers), Systemic Lupus Erythematosus Research (9 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Thomas Grader‐Beck collaborates with scholars based in United States, Switzerland and Germany. Thomas Grader‐Beck's co-authors include Alan N. Baer, Vassiliki A. Boussiotis, André A. F. L. van Puijenbroek, Julius Birnbaum, Fredrick M. Wigley, Esen K. Akpek, Jean Kim, Michelle Hessen, Priya M. Mathews and Lee M. Nadler and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Thomas Grader‐Beck

26 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Grader‐Beck United States 13 243 151 146 97 88 30 537
Jacques Éric Gottenberg France 8 313 1.3× 169 1.1× 195 1.3× 145 1.5× 60 0.7× 12 567
Antónia Szántó Hungary 12 239 1.0× 253 1.7× 239 1.6× 83 0.9× 95 1.1× 30 607
Ildikó Fanny Horváth Hungary 12 160 0.7× 177 1.2× 191 1.3× 54 0.6× 76 0.9× 18 465
Alja J. Stel Netherlands 14 386 1.6× 83 0.5× 86 0.6× 313 3.2× 117 1.3× 37 624
Bineta Ly France 10 133 0.5× 143 0.9× 86 0.6× 60 0.6× 46 0.5× 15 384
Saida Boudaoud France 12 404 1.7× 220 1.5× 174 1.2× 173 1.8× 70 0.8× 16 714
Erlin A. Haacke Netherlands 17 634 2.6× 214 1.4× 177 1.2× 378 3.9× 78 0.9× 31 847
Angelo De Lauretis Italy 13 140 0.6× 72 0.5× 119 0.8× 149 1.5× 356 4.0× 20 927
Sylvie Mistou France 11 277 1.1× 390 2.6× 223 1.5× 91 0.9× 53 0.6× 15 884
Thomas Guerrier France 12 98 0.4× 224 1.5× 75 0.5× 50 0.5× 151 1.7× 26 444

Countries citing papers authored by Thomas Grader‐Beck

Since Specialization
Citations

This map shows the geographic impact of Thomas Grader‐Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Grader‐Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Grader‐Beck more than expected).

Fields of papers citing papers by Thomas Grader‐Beck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Grader‐Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Grader‐Beck. The network helps show where Thomas Grader‐Beck may publish in the future.

Co-authorship network of co-authors of Thomas Grader‐Beck

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Grader‐Beck. A scholar is included among the top collaborators of Thomas Grader‐Beck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Grader‐Beck. Thomas Grader‐Beck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dörner, Thomas, Simon Bowman, Robert I. Fox, et al.. (2024). Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study. Arthritis & Rheumatology. 77(5). 560–570. 3 indexed citations
2.
3.
Grader‐Beck, Thomas, Uzma Haque, John B. Miller, et al.. (2024). Characteristics associated with patient-reported treatment success in psoriatic arthritis. Lara D. Veeken. 64(3). 1111–1121. 2 indexed citations
4.
Patel, Dipal, Thomas Grader‐Beck, Derek M. Fine, et al.. (2023). Dissemination and Early Experiences of an Electronic Patient-Reported Outcome Measure in Nephrology Clinic. Clinical Journal of the American Society of Nephrology. 18(9). 1204–1206. 1 indexed citations
5.
DiRenzo, Dana, Susan Robinson, Clifton O. Bingham, Alan N. Baer, & Thomas Grader‐Beck. (2022). PROMIS Provides a Broader Overview of Health-related Quality of Life Than the ESSPRI in Evaluation of Sjögren Syndrome. The Journal of Rheumatology. 49(5). 470–474. 1 indexed citations
6.
Grader‐Beck, Thomas, Kelly A. Gebo, Elizabeth Holmes, et al.. (2022). Designing an electronic medical record alert to identify hospitalised patients with HIV: successes and challenges. BMJ Health & Care Informatics. 29(1). e100521–e100521.
7.
Armağan, Berkan, Susan A. Robinson, Jamie Perin, et al.. (2021). Antibodies to Both Ro52 and Ro60 for Identifying Sjögren's Syndrome Patients Best Suited for Clinical Trials of Disease‐Modifying Therapies. Arthritis Care & Research. 74(9). 1559–1565. 18 indexed citations
8.
Bowman, Simon, Robert I. Fox, Thomas Dörner, et al.. (2021). Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial. The Lancet. 399(10320). 161–171. 115 indexed citations
9.
Baer, Alan N., Thomas Grader‐Beck, Brendan Antiochos, Julius Birnbaum, & Joel Fradin. (2020). Ultrasound‐Guided Biopsy of Suspected Salivary Gland Lymphoma in Sjögren’s Syndrome. Arthritis Care & Research. 73(6). 849–855. 24 indexed citations
10.
11.
Wu, Michael, et al.. (2019). Clinical Characteristics of Hydralazine-induced Lupus. Cureus. 11(6). e4996–e4996. 8 indexed citations
12.
Mathews, Priya M., Michelle Hessen, Jean Kim, et al.. (2015). Ocular Complications of Primary Sjögren Syndrome in Men. American Journal of Ophthalmology. 160(3). 447–452.e1. 26 indexed citations
13.
Akpek, Esen K., Priya M. Mathews, Michelle Hessen, et al.. (2014). Ocular and Systemic Morbidity in a Longitudinal Cohort of Sjögren’s Syndrome. Ophthalmology. 122(1). 56–61. 75 indexed citations
14.
Grader‐Beck, Thomas, Francesco Boin, Stephan von Gunten, et al.. (2011). Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular disease. Annals of the Rheumatic Diseases. 70(12). 2218–2224. 34 indexed citations
15.
Grader‐Beck, Thomas, et al.. (2007). Apoptotic Splenocytes Drive the Autoimmune Response to Poly(ADP-ribose) Polymerase 1 in a Murine Model of Lupus. The Journal of Immunology. 178(1). 95–102. 27 indexed citations
16.
Grader‐Beck, Thomas & Fredrick M. Wigley. (2005). Raynaud's Phenomenon in Mixed Connective Tissue Disease. Rheumatic Disease Clinics of North America. 31(3). 465–481. 38 indexed citations
17.
Grader‐Beck, Thomas, André A. F. L. van Puijenbroek, Lee M. Nadler, & Vassiliki A. Boussiotis. (2003). cAMP inhibits both Ras and Rap1 activation in primary human T lymphocytes, but only Ras inhibition correlates with blockade of cell cycle progression. Blood. 101(3). 998–1006. 42 indexed citations
18.
Appleman, Leonard J., Dimitrios Tzachanis, Thomas Grader‐Beck, André A. F. L. van Puijenbroek, & Vassiliki A. Boussiotis. (2002). Induction of Immunologic Tolerance for Allogeneic Hematopoietic Cell Transplantation. Leukemia & lymphoma. 43(6). 1159–1167. 6 indexed citations
19.
Appleman, Leonard J., Dimitrios Tzachanis, Thomas Grader‐Beck, André A. F. L. van Puijenbroek, & Vassiliki A. Boussiotis. (2001). Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics. Journal of Molecular Medicine. 78(12). 673–683. 43 indexed citations
20.
Grader‐Beck, Thomas, André A. F. L. van Puijenbroek, Lee M. Nadler, & Vassiliki A. Boussiotis. (2000). Increase of endogenous cyclic amp recapitulates functional and biochemical properties of t cell anergy. Blood. 96. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Éric Gottenberg Breakdown of academic impact, for papers by Antónia Szántó Breakdown of academic impact, for papers by Ildikó Fanny Horváth Breakdown of academic impact, for papers by Alja J. Stel Breakdown of academic impact, for papers by Bineta Ly Breakdown of academic impact, for papers by Saida Boudaoud Breakdown of academic impact, for papers by Erlin A. Haacke Breakdown of academic impact, for papers by Angelo De Lauretis Breakdown of academic impact, for papers by Sylvie Mistou Breakdown of academic impact, for papers by Thomas Guerrier
Rankless by CCL
2026